PXE INTERNATIONAL BIENNIAL RESEARCH SYMPOSIUM 2018

Information

  • Research Project
  • 9613363
  • ApplicationId
    9613363
  • Core Project Number
    R13TR002523
  • Full Project Number
    1R13TR002523-01
  • Serial Number
    002523
  • FOA Number
    PA-16-294
  • Sub Project Id
  • Project Start Date
    8/15/2018 - 7 years ago
  • Project End Date
    8/14/2019 - 6 years ago
  • Program Officer Name
    CHEN, ALICE
  • Budget Start Date
    8/15/2018 - 7 years ago
  • Budget End Date
    8/14/2019 - 6 years ago
  • Fiscal Year
    2018
  • Support Year
    01
  • Suffix
  • Award Notice Date
    8/7/2018 - 7 years ago
Organizations

PXE INTERNATIONAL BIENNIAL RESEARCH SYMPOSIUM 2018

This grant application requests support for a meeting, PXE International Biennial Research Symposium. The conference is part of a series of biennial research meetings on pseudoxanthoma elasticum (PXE), a metabolic condition for which there is no effective treatment or cure. These meetings are sponsored by PXE International, a not-for-profit organization advocating on behalf of patients with PXE and their families. The overall goal of this symposium is to provide an international forum for the cadre of premiere scientists working in fields relating to the pathomechanisms and organ involvement in PXE. The organizing committee has developed a program, with the specific aims to foster a greater understanding of the clinical problems of PXE; present and discuss advances in cutting edge scientific research on PXE; promote collaboration between basic scientists and clinicians; and provide opportunities for students, post-doctoral fellows and young investigators in the field with interest in pathogenesis and treatment of metabolic diseases. The thematic sessions focus on (1) review the basic science advances in genetics, genomics and diagnostics; (2) animal models; (3) Clinical Phenotypes and Phenotype/Genotype Correlations of Ectopic Mineralization Disorders; (4) Outcome Measures for Clinical Trials; and (5) potential therapeutics. The audience is expected to consist of ~100 participants, including a significant number of young and new investigators in the field ? students, fellows, and junior faculty. The organizers will also reach out to communities of under-represented minorities with invitations and incentives to participate in this meeting, towards building a pipeline of future minority researchers in cutaneous biology and particularly PXE. We believe that the planned meeting is extremely timely, and it is expected to prove its usefulness in bringing interdisciplinary approaches for the research themes for the future with focus on developing molecular approaches for treatment for PXE and related conditions.

IC Name
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
  • Activity
    R13
  • Administering IC
    TR
  • Application Type
    1
  • Direct Cost Amount
    17000
  • Indirect Cost Amount
    0
  • Total Cost
    17000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    351
  • Ed Inst. Type
  • Funding ICs
    NCATS:15000\NIAMS:2000\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    ZTR1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    PXE INTERNATIONAL, INC.
  • Organization Department
  • Organization DUNS
    102187916
  • Organization City
    WASHINGTON
  • Organization State
    DC
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    200082304
  • Organization District
    UNITED STATES